Citywire for Financial Professionals
Stay connected:

View the article online at http://citywire.co.uk/money/article/a877236

Woodford must be Patient to earn crust on trust

Neil Woodford needs to grow his Woodford Patient Capital trust by over 35% to make any money from it this year.  

 
Woodford must be Patient to earn crust on trust

Star fund manager Neil Woodford faces a tough task if he is to make any money from his Patient Capital (WPCT ) investment trust this year.

When it launched last year one of the investment trust's selling points, aside from its focus on early stage healthcare companies, was its innovative performance fee structure which sees Woodford's company, Woodford Investment Management, paid only if the trust grows its investment portfolio by more than 10% a year. Note, this is measured by the growth in the trust's net asset value (NAV) not the performance of its share price. 

A separate annual expenses charge is also levied, although it is not expected to exceed 0.2% and Woodford does not derive any revenue from it.

With the biotech sell-off having dented the trust's net asset value, Woodford will fail to earn a fee for his performance last year, and it will take a stellar run if he is to make any money this year.

Woodford's first opportunity to earn a fee came at the end of 2015, in a shortened financial year for the trust covering the period from its launch on 21 April. To earn his fee, the manager had to deliver NAV per share of 106.96p (based on a pro rata calculation of the 10% annual hurdle over eight months). However, by 31 December the NAV stood at around 97p per share, well below that.

Had he cleared that hurdle, Woodford would have received 15% of returns above the 106.96p mark.

Since then, the NAV has fallen further, leaving Woodford with an even tougher challenge in winning his fee for 2016. The hurdle for a 2016 payment is set at 10% more than 2015's 106.96p target, or 117.65p.

The latest NAV for the trust, at Thursday's close, was 86.7p. This means Woodford needs to grow the portfolio by 35.7% this year to even clear that hurdle, and more than that to make any money.

The nature of early stage investing, particularly with unquoted companies, means that when they go well, they can deliver spectacular returns: witness the 491% return on the Woodford Equity Income fund's investment in biotech business Stratified Medical, and the similar performance delivered by its investment in online estate agent Purplebricks (PURP), which has since listed on the Alternative Investment Market. The trust will need more investments like these if Woodford is to earn a fee for 2016.

There's no sign from Woodford of any lack of confidence. Just last month the trust announced it was considering raising more money given the 'ongoing pipeline of investment opportunities'. And while that move drew criticism from some investors given the trust's lacklustre returns to date, it's worth noting that Woodford won't garner any fees on that new money unless he delivers some striking outperformance.

Funds cash out

Some early investors have already headed for the exit, however. They include Paul Smith, manager of the Sentinel Defensive fund, who bought a £902,545 stake in the trust only to then sell out at a profit, for £954,330, thanks to the premium to NAV that has built up on the trust's shares, hitting 15% at its peak. Likewise the Seneca Diversified Growth fund and the Smith & Williamson Multi-Manager Global Investment fund.

Some, including readers of this site, sold shares in the trust due to the heavy premium that had built up. Iain Scouller, analyst at Stifel, slapped a 'sell' rating on the trust in July due to the premium, spurred by investor enthusiasm and buying from tracker funds as the trust entered the FTSE 250.

However, he has since moved to a 'hold' rating as the premium subsided, with the shares no trading at par to NAV, according to the latest figures from Numis Securities.

In a note issued in November, Scouller said he thought 'the shares should trade close to NAV, rather than on a large premium, given the immaturity of the portfolio, with many of the unquoted investments expected to take some years to mature and be realised through initial public offerings or sales.'

The trust meanwhile retains a number of high profile fund manager backers. The largest fund shareholder, according to Reuters, is the £2.6 billion BlackRock Dynamic Diversified Growth fund, managed by Adam Ryan and Andy Warwick, which holds 2% of the trust's shares.

Ruffer is another big backer, with a stake worth £9.1 million held by the Total Return fund run by David Ballance and Steve Russell, and one worth around £810,000 held by the European fund run by Citywire A-rated Timothy Youngman, according to the funds' annual report for the year to 15 September.

Algy Smith-Maxwell is another backer, holding the trust in his Jupiter Merlin Real Return fund, which is the trust's third largest fund shareholder.

A smaller holding, worth around £400,000 is held by M&G Fund of Investment Trust Shares , according to the fund's annual report, issued last year.

'The UK excels in life sciences and has a strong academic reputation but many products are subsequently commercialised outside the UK because of a lack of long-term capital investment at home,' said manager Richard O'Connor in the report.

'The trust's highly experienced fund manager seeks to address this use by investing in carefully chosen businesses, with the aim of helping them to fulfil their potential.'

5 comments so far. Why not have your say?

colin overton

Feb 01, 2016 at 16:08

There is a problem when a manager receives no payment, particularly if this is repeated for a few years. Why would he spend any of his time working on the portfolio of investments? Woodford has other responsibilities so it's not a matter of working on "Patient" or doing nothing. I hope there will not happen for several years, but I had a VCT where this did seem to happen.

report this

Powerful Pierre

Feb 01, 2016 at 21:40

Give the man a chance! It's called Patient Capital for a reason and bemoaning the fact he's had a relatively bad year misses the point entirely. And, after all, the wider market's performance has not exactly been stellar.

report this

kWIKSAVE

Feb 01, 2016 at 22:37

Judge Woody after 5 years.

report this

albion

Feb 02, 2016 at 00:10

Off topic. Citywire seems to have an obsession with Woodford. Hardly a week passes without a reference to him in one way or another.

report this

RL

Feb 07, 2016 at 15:30

Investment Trust launches are doomed to repetitive failures (MEPIT? Fidelity China Special Sits?). You need an excess of enthusiasm to launch a Trust, so pretty much by definition it's the top of the market. How many times has this happened?! Amazing how even the most experienced fund managers get caught up in the hype. It's always obvious from the level of oversubscription. The hype is dying down, and now is probably not a bad entry point - though I'd probably give it another year and wait for the discount to open up.

report this

leave a comment

Please sign in here or register here to comment. It is free to register and only takes a minute or two.

News sponsored by:

Sponsored Video: The sterling slump: what’s next?


After Boris announced he was backing Brexit, sterling suffered its biggest slump in six years. Our Market Mavens discuss. Follow the Market Mavens LinkedIn page for weekly videos, in which our panel of industry experts share their views on financial news

The Citywire guide to investment trusts

In association with Aberdeen Asset Management

More about this:

Look up the funds

  • CF Woodford Equity Income C Inc
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Sentinel Defensive Portfolio A Acc
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • CF Seneca Diversified Growth Fund A Class
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Blackrock Dynamic Diversified Growth A Acc
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • CF Ruffer Total Return O Inc
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • CF Ruffer European O Acc
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Jupiter Merlin Real Return I GBP Acc HSC
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • M&G Fund of Investment Trust Shares A Inc
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Look up the shares

  • Purplebricks Group PLC
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Look up the investment trusts

Look up the fund managers

  • Neil Woodford
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Paul Smith
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Adam Ryan
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Andrew Warwick
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • David Ballance
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Steve Russell
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Timothy Youngman
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Algy Smith-Maxwell
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Richard O'Connor
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them

More from us

Archive

Today's articles

Tools from Citywire Money

From the Forums

+ Start a new discussion

Weekly email from The Lolly

Get simple, easy ways to make more from your money. Just enter your email address below

An error occured while subscribing your email. Please try again later.

Thank you for registering for your weekly newsletter from The Lolly.

Keep an eye out for us in your inbox, and please add noreply@emails.citywire.co.uk to your safe senders list so we don't get junked.

Read more...

Investment Trust Watch: Europe sell-off reignites

by Daniel Grote on May 27, 2016 at 12:48

Sorry, this link is not
quite ready yet